HAT

This study was set-up in order to determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in developed and developing countries.

Therapeutic areas

Total patients

698

Total sites

150

Status

Finished

HAT was a non interventional, multicenter, study using a self assessment questionnaire and patient diaries, and included 27,585 patients, aged ≥18 years, with type 1 diabetes or type 2 diabetes treated with insulin for >12 months, at 2004 sites in 24 countries worldwide. The primary endpoint was the proportion of patients experiencing at least one hypoglycemic event during the observational period.

Julius Clinical recruited 698 patients from 150 different general practitioner sites throughout the Netherlands. 

Publications

Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes

Kamlesh, Kamlesh et al., “Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes”. Diabetes Research and Clinical Practice 130 (2017) 121–129. 

show details

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study.

Khunti, Kamlesh, et al. "Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study." Diabetes, Obesity and Metabolism 18.9 (2016): 907-915.

show details